Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JARVIS, M. F")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3
Export

Selection :

  • and

Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive miceJARVIS, M. F; WILLIAMS, M.Pharmacology, biochemistry and behavior. 1988, Vol 30, Num 3, pp 707-714, issn 0091-3057Article

Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680JARVIS, M. F; WILLIAMS, M.European journal of pharmacology. 1989, Vol 168, Num 2, pp 243-246, issn 0014-2999Article

Purinergic and pyrimidinergic receptors as potential drug targetsWILLIAMS, M; JARVIS, M. F.Biochemical pharmacology. 2000, Vol 59, Num 10, pp 1173-1185, issn 0006-2952Article

[3H]5'-N-ethylcarboxamidoadenosine selectively labels the low affinity adenosine binding protein, adenotin, on intact Chinese hamster ovary cellsJARVIS, M. F; SALTZMAN, A.Drug development research. 1993, Vol 29, Num 4, pp 305-309, issn 0272-4391Article

Differential effects of the adenosine A1 receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranesJARVIS, M. F; GESSNER, G; SHAPIRO, G et al.Brain research. 1999, Vol 840, Num 1-2, pp 75-83, issn 0006-8993Article

Single and repeated episodes of ethanol withdrawal increase adenosine A1, but not A2A, receptor density in mouse brainJARVIS, M. F; BECKER, H. C.Brain research. 1998, Vol 786, Num 1-2, pp 80-88, issn 0006-8993Article

Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes : inhibitory effects of heparin, pertussis toxin and guanine nucleotidesJARVIS, M. F; GESSNER, G. W; MARTIN, G. E et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 263, Num 1, pp 253-263, issn 0022-3565Article

L-dopa reverses the effects of MPP+ toxicityWAGNER, G. C; JARVIS, M. F; RUBIN, J. G et al.Psychopharmacologia. 1986, Vol 88, Num 3, pp 401-402, issn 0033-3158Article

Cocaine blocks the dopamine depletion induced by MPTPMAYER, R. A; JARVIS, M. F; WAGNER, G. C et al.Research communications in chemical pathology and pharmacology. 1985, Vol 49, Num 1, pp 145-148, issn 0034-5164Article

P2X7-related modulation of pathological nociception in ratsMCGARAUGHTY, S; CHU, K. L; FABIYI, A. C et al.Neuroscience. 2007, Vol 146, Num 4, pp 1817-1828, issn 0306-4522, 12 p.Article

An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic painLYNCH, J. J; JARVIS, M. F; KOWALUK, E. A et al.European journal of pharmacology. 1999, Vol 364, Num 2-3, pp 141-146, issn 0014-2999Article

Dithiothreitol, sodium chloride, and ethylenediaminetetraacetic acid increase the binding affinity of [125I]angiotensin IV to AT4 receptors in bovine adrenal cortexJARVIS, M. F; GESSNER, G. W.Peptides (New York, NY. 1980). 1994, Vol 15, Num 6, pp 1037-1044, issn 0196-9781Article

Chronic theophylline prolongs the refractory period in amygdala-kindled ratsKLEINSORGE, R. J; BOWERS, L. M; JARVIS, M. F et al.Drug development research. 1993, Vol 29, Num 4, pp 287-291, issn 0272-4391Article

High selective adenosine A2 receptor agonsits in a series of N-alkylated 2-aminoadenosinesFRANCIS, J. E; WEBB, R. L; BARCLAY, B et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 8, pp 2570-2579, issn 0022-2623Article

Autoradiographic characterization of high-affinity adenosine A2 receptors in the rat brainJARVIS, M. F; JACKSON, R. H; WILLIAMS, M et al.Brain research. 1989, Vol 484, Num 1-2, pp 111-118, issn 0006-8993Article

[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brainJARVIS, M. F; SCHULZ, R; HUTCHISON, A. J et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 251, Num 3, pp 888-893, issn 0022-3565Article

Lack of specificity of [35S]-ATPγS and [35S]-ADPβS as radioligands for lonotropic and metabotropic P2 receptor bindingHAIXIA YU; BIANCHI, B; METZGER, R et al.Drug development research. 1999, Vol 48, Num 2, pp 84-93, issn 0272-4391Article

Differential expression of adenosine A2A and A2Breceptor subtypes on myeloid U937 and THP-1 cells : Adenosine A2Breceptor activation selectively stimulates cAMP formation and inhibition of TNFα release in THP-1 cellsMUNRO, R; RESSNER, R; STONE, M et al.Drug development research. 1998, Vol 44, Num 1, pp 41-47, issn 0272-4391Article

Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotectiveMERKEL, L; ROJAS, C. J; JARVIS, M. F et al.Drug development research. 1998, Vol 45, Num 1, pp 30-43, issn 0272-4391Article

Adenosine kinase inhibitorsKOWALUK, E. A; BHAGWAT, S. S; JARVIS, M. F et al.Current pharmaceutical design. 1998, Vol 4, Num 5, pp 403-416, issn 1381-6128Article

Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acidJARVIS, M. F; BURNS, C. J; PAULS, H. W et al.Calcified tissue international. 1993, Vol 52, Num 5, pp 372-377, issn 0171-967XArticle

Differential effects of early chronic lead exposure on postnatal rat brain NMDA, PCP, and adenosine A1 receptors : an autoradiographic studyBROOKS, W. J; PETIT, T. L; LEBOUTILLIER, J. C et al.Drug development research. 1993, Vol 29, Num 1, pp 40-47, issn 0272-4391Article

Chronic theophylline treatment in vivo incrases high affinity adenosine A1 receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal sliceLUPICA, C. R; JARVIS, M. F; BERMAN, R. F et al.Brain research. 1991, Vol 542, Num 1, pp 55-62, issn 0006-8993, 8 p.Article

Species differences in high-affinity adenosine A2 binding sites in striatal membranes from mammalian brainSTONE, G. A; JARVIS, M. F; SILLS, M. A et al.Drug development research. 1988, Vol 15, Num 1, pp 31-46, issn 0272-4391Article

ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painJARVIS, M. F; WESSALE, J. L; ZHU, C. Z et al.European journal of pharmacology. 2000, Vol 388, Num 1, pp 29-35, issn 0014-2999Article

  • Page / 3